Literature DB >> 9255827

Invariance of ophthalmic properties under spherocylindrical transposition.

W F Harris1.   

Abstract

Ophthalmic properties expressed as functions of dioptric power cannot depend on the particular spherocylindrical form (positive or negative cylinder) chosen to represent the power: they are necessarily invariant under spherocylindrical transposition. This condition of invariance places restrictions on the mathematical form that valid ophthalmic functions can assume. Tests are presented for checking the validity of proposed ophthalmic functions and properties. Examples from the literature are examined, including Keating's concept of torsional power and Peters' graphs of expected unaided visual acuity vs. ametropia. The former satisfies the condition of invariance but the latter are shown to violate the condition for ametropias which are close to spherical. The analysis shows partly how the graphs need to be refined. Invariance under spherocylindrical transposition can assist the researcher in developing new concepts and relationships that depend on power expressed in terms of sphere, cylinder, and axis.

Entities:  

Mesh:

Year:  1997        PMID: 9255827     DOI: 10.1097/00006324-199706000-00032

Source DB:  PubMed          Journal:  Optom Vis Sci        ISSN: 1040-5488            Impact factor:   1.973


  3 in total

Review 1.  Objective evaluation of refractive data and astigmatism: quantification and analysis.

Authors:  S B Kaye
Journal:  Eye (Lond)       Date:  2013-12-13       Impact factor: 3.775

2.  Refractive outcomes following cataract surgery in patients who have had myopic laser vision correction.

Authors:  Chung Shen Chean; Boon Kang Aw Yong; Samuel Comely; Deena Maleedy; Stephen Kaye; Mark Batterbury; Vito Romano; Esmaeil Arbabi; Victor Hu
Journal:  BMJ Open Ophthalmol       Date:  2019-04-09

3.  Standardised approach to the reporting and presentation of refractive data: electronic patient record.

Authors:  Stephen B Kaye; Alan Rubin; Tanya Evans; Petros Aristodemou; Anthony Khawaja; John Sparrow
Journal:  BMJ Open Ophthalmol       Date:  2022-04-01
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.